Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jan;41(1):149-54.
doi: 10.1128/JCM.41.1.149-154.2003.

Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR

Affiliations

Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR

Aizhong Hu et al. J Clin Microbiol. 2003 Jan.

Abstract

Timely diagnosis of respiratory syncytial virus (RSV) infection is critical for appropriate treatment of lower respiratory infection in young children. To facilitate diagnosis, we developed a rapid, specific, and sensitive TaqMan PCR method for detection of RSV A and RSV B. Two sets of primer-probe pairs were selected from the nucleotide sequences encoding the nucleocapsid protein--one targeting RSV A and the other targeting RSV B. The specificity of the TaqMan reverse transcription-PCR assay was evaluated by testing each primer-probe pair against various viruses derived from laboratory virus stocks, as well as clinical respiratory specimens. Fluorescent signals were observed only in the presence of RSV A and/or RSV B. The sensitivity of our quantitative PCR assay was determined on the basis of PFU and virus particle counts. The resulting assay sensitivity was found to be 0.023 PFU, or two copies of viral RNA, for RSV A and 0.018 PFU, or nine copies of viral RNA, for RSV B. This quantitative TaqMan PCR assay was utilized to diagnose 175 nasopharyngeal aspirates obtained from children in Hong Kong with respiratory symptoms during the winter of 2000 and 2001. Among these specimens, TaqMan PCR detected 36 RSV-positive samples, 10 of which were identified as RSV A and 26 of which were identified as RSV B, whereas culture confirmation identified 21 RSV-positive specimens and immunofluorescence identified 32 RSV-positive specimens, all of which were among those identified by PCR. The results confirmed the accuracy of our TaqMan PCR assay and demonstrated its improved sensitivity versus classical methods.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Specificity of RSV primer-probe pairs. RSV A primer pair A21-A102 and probe APB48 (a) and RSV B primer pair B17-B120 and probe BPB45 (b) were employed to detect RSV A2 (▪) and 2B (⧫) RNAs.
FIG. 2.
FIG. 2.
Sensitivity of the TaqMan RT-PCR assay. Tenfold serial dilutions of the RNA extracted from RSV A2 (0.0023 PFU to 230 PFU) (a) and RSV 2B (0.0018 PFU to 180 PFU) (b) were used in the PCR. Primer-probe pairs specific for RSV A (a) and B (b) were employed to detect the corresponding targets. The negative control contained RNase-free water instead of RNA template.
FIG. 2.
FIG. 2.
Sensitivity of the TaqMan RT-PCR assay. Tenfold serial dilutions of the RNA extracted from RSV A2 (0.0023 PFU to 230 PFU) (a) and RSV 2B (0.0018 PFU to 180 PFU) (b) were used in the PCR. Primer-probe pairs specific for RSV A (a) and B (b) were employed to detect the corresponding targets. The negative control contained RNase-free water instead of RNA template.
FIG. 3.
FIG. 3.
RSV-positive clinical specimens analyzed by TaqMan PCR. The samples were collected and analyzed as described in Materials and Methods. The threshold cycle (CT) represents the cycle number at which a significant increment of fluorescence signal is first detected. Each symbol represents the CT number for an individual specimen.

References

    1. American Academy of Pediatrics, Committee on Infectious Diseases. 1996. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics 97:137-140. - PubMed
    1. American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. 1998. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. Pediatrics 102:1211-1216. - PubMed
    1. Anderson, L. J., J. C. Hierholzer, C. Tsou, R. M. Hendry, B. F. Fernie, Y. Stone, and K. McIntosh. 1985. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J. Infect. Dis. 151:626-633. - PubMed
    1. Buckingham, S. C., A. J. Bush, and J. P. Devincenzo. 2000. Nasal quantity of respiratory syncytial virus correlates with disease severity in hospitalized infants. Pediatr. Infect. Dis. J. 19:113-117. - PubMed
    1. Cha, T., K. Kao, J. Zhao, P. E. Fast, P. M. Mendelman, and A. Arvin. 2000. Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial. J. Clin. Microbiol. 38:839-845. - PMC - PubMed

MeSH terms

LinkOut - more resources